CCL17 and classic Hodgkin lymphoma: In adults, approximately 90% of cHL patients show positive TARC staining of HRS cells by immunohistochemistry and about 82‐93% of patients have significantly elevated TARC levels in their pretreatment serum [10, 11, 12, 13].